Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Author(s) -
Robert L. Coleman,
Nick M. Spirtos,
Danielle Enserro,
Thomas J. Herzog,
Paul Sabbatini,
Deborah K. Armstrong,
JaeWeon Kim,
SangYoon Park,
ByoungGie Kim,
Joo-Hyun Nam,
Keiichi Fujiwara,
Joan L. Walker,
A.Catherine Casey,
Angeles Alvarez Secord,
Steve Rubin,
John K. Chan,
Paul DiSilvestro,
Susan A. Davidson,
David E. Cohn,
Krishnansu S. Tewari,
Karen BasenEngquist,
Helen Q. Huang,
Mark F. Brady,
Robert S. Mannel
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1902626
Subject(s) - medicine , ovarian cancer , fallopian tube , fallopian tube cancer , epithelial ovarian cancer , surgery , oncology , gynecology , general surgery , cancer
Secondary surgical cytoreduction in women with platinum-sensitive, recurrent epithelial ovarian, primary peritoneal, or fallopian-tube ("ovarian") cancer is widely practiced but has not been evaluated in phase 3 investigation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom